Skip to Content
  • MyChart

    Log in to our secure, personalized website to manage your care (formerly myMDAnderson).

  • Request an Appointment

    If you are ready to make an appointment, select a button on the right. If you have questions about UT MD Anderson’s appointment process, our information page may be the best place to start.

    Appointment Information
    New Patients Current Patients Referring Physicians
  • Every Breakthrough
    Begins With You

    Gifts to UT MD Anderson’s historic philanthropic campaign help accelerate discovery, transform lives and bring hope to more patients than ever before.

    Learn more about Only Possible Here
    Donate Today only-possible-here-logo
The University of Texas MD Anderson Cancer Center
  • Clinical Trials
  • Locations
  • Careers
  • Contact Us
  • Our Doctors
    • Español
    • عربى
    • 中文
    • Türkçe
Clear
close
      MyChart
      Donate Today
      • Clinical Trials
      • Locations
      • Careers
      • Contact Us
        • Español
        • عربى
        • 中文
        • Türkçe
      • Request an Appointment
      • New Patients
      • Current Patients
      • Referring Physicians
      • Patients & Family
          • Becoming Our Patient Home
          • Why UT MD Anderson
          • Planning for Care
          • Getting to UT MD Anderson
          • While You're Here
          • International Center
          • Services and Amenities
          • Insurance & Billing
          • Second Opinion Appointments
          • Diagnosis & Treatment Home
          • Cancer Types
          • A New Diagnosis
          • Treatment Options
          • Care Centers & Clinics
          • Emotional & Physical Effects
          • Patient Support
          • Clinical Trials
          • Supporting a Loved One Home
          • Caregiver Roles & Challenges
          • Children and Teens
          • Taking Care of Yourself
          • Helping a UT MD Anderson Patient
          • Dealing with Loss
          • Life After Cancer Home
          • Follow-up Care After Cancer Treatment
          • Long-Term Effects of Cancer
          • Social & Emotional Impacts of Cancer
          • Legal & Financial Impacts of Cancer
          • Survivorship Week
        • Request an Appointment Current Patients

          Find information and resources for current and returning patients.

          Clinical Trials

          Learn about clinical trials at UT MD Anderson and search our database for open studies.

      • Prevention & Screening
          • Manage Your Risk Home
          • Tobacco Control
          • Diet
          • Body Weight
          • Physical Activity
          • Skin Safety
          • HPV
          • Hepatitis
          • Alcohol
          • Family History Home
          • Genetic Testing
          • Hereditary Cancer Syndromes
          • Genetic Counseling and Testing FAQs
          • Cancer Screenings Home
          • Mammograms & Breast Cancer Screening
          • Cervical Cancer Screening
          • Colorectal Cancer Screening
          • Endometrial Cancer Screening
          • Liver Cancer Screening
          • Lung Cancer Screening
          • Mobile Mammography
          • Ovarian Cancer Screening
          • Prostate Cancer Screening
          • Skin Cancer Screening
          • Women's Cancer Screening
          • Men's Cancer Screening
        • Cancer Prevention Center 

          The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

      • Donors & Volunteers
          • Donate Home
          • Raise Money
          • Honor Loved Ones
          • Create Your Legacy
          • Endowments
          • Caring Fund
          • Matching Gifts
          • Foundation and Corporation Relations
          • Volunteer Home
          • Why Volunteer
          • On-Site Volunteers
          • Volunteer Endowment
          • Patient Experience
          • Teen Volunteer Leadership Program
          • Children's Cancer Hospital Councils
          • Other Ways to Help Home
          • Give Blood
          • Shop UT MD Anderson
          • Children's Art Project
          • Donate Goods or Services
          • Attend Events
          • Cord Blood Bank
          • Corporate Alliances Home
          • Current Alliances
        • Join the Campaign to End Cancer 

          Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define UT MD Anderson.

      • For Physicians
          • Refer a Patient Home
          • Health Care Provider Resource Center
          • Referring Provider Team
          • Insurance Information
          • International Referrals
          • myMDAnderson for Physicians
          • Second Opinion Pathology
          • Clinical Trials Home
          • Clinical Tools & Resources Home
          • Clinical Calculators
          • Clinical Practice Algorithms
        • myMDAnderson for Physicians 

          Our personalized portal helps you refer your patients and communicate with their UT MD Anderson care team.

      • Research
          • Departments, Labs and Institutes Home
          • Departments and Divisions
          • Labs
          • Research Centers and Programs
          • Institutes
          • Specialized Programs of Research Excellence (SPORE) Grants
          • Research Areas Home
          • Basic Science
          • Translational Research
          • Clinical Research
          • Prevention & Personalized Risk Assessment
          • Research Resources Home
          • Excellence in Science
          • Core Facilities and Services
          • Conferences & Seminars
          • Why Research at UT MD Anderson
          • STRIDE
          • NCI-Designated Cancer Center
          • Data Resources
        • Clinical Trials 

          As part of our mission to eliminate cancer, UT MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

      • Education & Training
          • Degree-Granting Schools Home
          • School of Health Professions
          • MD Anderson UTHealth Houston Graduate School
          • Research Training Home
          • Early Career Pathway Programs
          • Predoctoral Training
          • Postdoctoral Training
          • Mentored Faculty Programs
          • Career Development
          • Clinical Training Home
          • Graduate Medical Education
          • Clinical Education for Non-Physicians
          • Nursing Education & Training
          • Continuing Education & Review Courses
          • Simulation Center
          • Continuing Education & Professional Development Home
          • Continuing Professional Education/Conferences
          • Administrative Internships & Fellowships
          • Cancer Survivorship Professional Education
          • Leadership Institute
          • Patient Home Visits
          • Education Resources Home
          • Alumni Relations
          • Education Design Services
          • Awards & Recognitions
          • Academic Mentoring Council
          • Why UT MD Anderson & Houston
          • Outreach Programs Home
          • Project ECHO
          • Observer Programs
          • Comparative Effectiveness Training (CERTaIN)
          • Faculty Speakers Bureau
        • Apply to SHP

          Choose from 12 allied health programs at School of Health Professions.

          Research Trainees

          View open postdoctoral and other research trainee positions.

          GME Fellowships

          Learn about our graduate medical education residency and fellowship opportunities.

      Muhammad Aminu Image

      Muhammad Aminu, PHD

      Department of Imaging Physics, Division of Diagnostic Imaging

      Present Title & Affiliation

      Primary Appointment

      Instructor, Imaging Physics - Research, The University of Texas MD Anderson Cancer Center, Houston, Texas

      Dual/Joint/Adjunct Appointment

      Instructor, Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas

      Education & Training

      Degree-Granting Education

      2021Universiti Sains Malaysia, Gelugur, Pulau Pinang, MY, Mathematics (Machine Learning), PhD
      2015Kano University of Science and Technology Wudil, Wudil, Kano, NG, Mathematics, BSc

      Experience & Service

      Other Professional Positions

      Graduate Research Assistant, Universiti Sains Malaysia, Gelugur, Pulau Pinang, 2018 - 2020

      National Youth Service Corp Member, Abubakar Tafawa Balewa University, Bauchi, 2015 - 2016

      Student Industrial Work Experience Scheme (SIWES), Bayero University Kano, Kano, 2013 - 2013

      Honors & Awards

      2015Silver Medal award at National Mathematics Competition for University Students (NAMCUS), National Mathematical Centre Abuja, Nigeria
      2014Best graduating student of the department of Mathematics, Kano University of Science and Technology Wudil

      Professional Memberships

      American Association for Cancer Research

      2024 - Present

      International Association for the Study of Lung Cancer

      2024 - Present

      American Society of Clinical Oncology

      2023 - Present

      Selected Publications

      Peer-Reviewed Articles

      1. Aminu M, Hong L, Vokes N, Schmidt ST, Saad M, Zhu B, Le X, Tina C, Sheshadri A, Wang B, Jaffray D, Futreal A, Lee JJ, Byers LA, Gibbons D, Heymach J, Chen K, Cheng C, Zhang J, Wu J. Joint multi-omics discriminant analysis with consistent representation learning using PANDA. Res Sq, 2024. e-Pub 2024. PMID: 38798352.
      2. Sujit SJ, Aminu M, Karpinets TV, Chen P, Saad MB, Salehjahromi M, Boom JD, Qayati M, George JM, Allen H, Antonoff MB, Hong L, Hu X, Heeke S, Tran HT, Le X, Elamin YY, Altan M, Vokes NI, Sheshadri A, Lin J, Zhang J, Lu Y, Behrens C, Godoy MCB, Wu CC, Chang JY, Chung C, Jaffray DA, Wistuba II, Lee JJ, Vaporciyan AA, Gibbons DL, Heymach J, Zhang J, Cascone T, Wu J. Enhancing NSCLC recurrence prediction with PET/CT habitat imaging, ctDNA, and integrative radiogenomics-blood insights. Nat Commun 15(1):3152, 2024. e-Pub 2024. PMID: 38605064.
      3. Salehjahromi M, Karpinets TV, Sujit SJ, Qayati M, Chen P, Aminu M, Saad MB, Bandyopadhyay R, Hong L, Sheshadri A, Lin J, Antonoff MB, Sepesi B, Ostrin EJ, Toumazis I, Huang P, Cheng C, Cascone T, Vokes NI, Behrens C, Siewerdsen JH, Hazle JD, Chang JY, Zhang J, Lu Y, Godoy MCB, Chung C, Jaffray D, Wistuba I, Lee JJ, Vaporciyan AA, Gibbons DL, Gladish G, Heymach JV, Wu CC, Zhang J, Wu J. Synthetic PET from CT improves diagnosis and prognosis for lung cancer: Proof of concept. Cell Rep Med 5(3):101463, 2024. e-Pub 2024. PMID: 38471502.
      4. Tran HT, Heeke S, Sujit S, Vokes N, Zhang J, Aminu M, Lam VK, Vaporciyan A, Swisher SG, Godoy MCB, Cascone T, Sepesi B, Gibbons DL, Wu J, Heymach JV. Circulating tumor DNA and radiological tumor volume identify patients at risk for relapse with resected, early-stage non-small-cell lung cancer. Ann Oncol 35(2):183-189, 2024. e-Pub 2024. PMID: 37992871.
      5. Chen P, Rojas FR, Hu X, Serrano A, Zhu B, Chen H, Hong L, Bandyoyadhyay R, Aminu M, Kalhor N, Lee JJ, El Hussein S, Khoury JD, Pass HI, Moreira AL, Velcheti V, Sterman DH, Fukuoka J, Tabata K, Su D, Ying L, Gibbons DL, Heymach JV, Wistuba II, Fujimoto J, Solis Soto LM, Zhang J, Wu J. Pathomic Features Reveal Immune and Molecular Evolution From Lung Preneoplasia to Invasive Adenocarcinoma. Mod Pathol 36(12):100326, 2023. e-Pub 2023. PMID: 37678674.
      6. Diao S, Chen P, Showkatian E, Bandyopadhyay R, Rojas FR, Zhu B, Hong L, Aminu M, Saad MB, Salehjahromi M, Muneer A, Sujit SJ, Behrens C, Gibbons DL, Heymach JV, Kalhor N, Wistuba II, Solis Soto LM, Zhang J, Qin W, Wu J. Automated Cellular-Level Dual Global Fusion of Whole-Slide Imaging for Lung Adenocarcinoma Prognosis. Cancers (Basel) 15(19), 2023. e-Pub 2023. PMID: 37835518.
      7. Saad MB, Hong L, Aminu M, Vokes NI, Chen P, Salehjahromi M, Qin K, Sujit SJ, Lu X, Young E, Al-Tashi Q, Qureshi R, Wu CC, Carter BW, Lin SH, Lee PP, Gandhi S, Chang JY, Li R, Gensheimer MF, Wakelee HA, Neal JW, Lee HS, Cheng C, Velcheti V, Lou Y, Petranovic M, Rinsurongkawong W, Le X, Rinsurongkawong V, Spelman A, Elamin YY, Negrao MV, Skoulidis F, Gay CM, Cascone T, Antonoff MB, Sepesi B, Lewis J, Wistuba II, Hazle JD, Chung C, Jaffray D, Gibbons DL, Vaporciyan A, Lee JJ, Heymach JV, Zhang J, Wu J. Predicting benefit from immune checkpoint inhibitors in patients with non-small-cell lung cancer by CT-based ensemble deep learning: a retrospective study. Lancet Digit Health 5(7):e404-e420, 2023. e-Pub 2023. PMID: 37268451.
      8. Aminu, M, Ahmad, NA. Effective Dimensionality Reduction Using Kernel Locality Preserving Partial Least Squares Discriminant Analysis. Bulletin of the Malaysian Mathematical Sciences Society 46(3), 2023. e-Pub 2023.
      9. Hong L, Aminu M, Li S, Lu X, Petranovic M, Saad MB, Chen P, Qin K, Varghese S, Rinsurongkawong W, Rinsurongkawong V, Spelman A, Elamin YY, Negrao MV, Skoulidis F, Gay CM, Cascone T, Gandhi SJ, Lin SH, Lee PP, Carter BW, Wu CC, Antonoff MB, Sepesi B, Lewis J, Gibbons DL, Vaporciyan AA, Le X, Jack Lee J, Roy-Chowdhuri S, Routbort MJ, Gainor JF, Heymach JV, Lou Y, Wu J, Zhang J, Vokes NI. Efficacy and clinicogenomic correlates of response to immune checkpoint inhibitors alone or with chemotherapy in non-small cell lung cancer. Nat Commun 14(1):695, 2023. e-Pub 2023. PMID: 36755027.
      10. Aminu M, Daver N, Godoy MCB, Shroff G, Wu C, Torre-Sada LF, Goizueta A, Shannon VR, Faiz SA, Altan M, Garcia-Manero G, Kantarjian H, Ravandi-Kashani F, Kadia T, Konopleva M, DiNardo C, Pierce S, Naing A, Kim ST, Kontoyiannis DP, Khawaja F, Chung C, Wu J, Sheshadri A. Heterogenous lung inflammation CT patterns distinguish pneumonia and immune checkpoint inhibitor pneumonitis and complement blood biomarkers in acute myeloid leukemia: proof of concept. Front Immunol 14:1249511, 2023. e-Pub 2023. PMID: 37841255.
      11. Aminu M, Yadav D, Hong L, Young E, Edelkamp P Jr, Saad M, Salehjahromi M, Chen P, Sujit SJ, Chen MM, Sabloff B, Gladish G, de Groot PM, Godoy MCB, Cascone T, Vokes NI, Zhang J, Brock KK, Daver N, Woodman SE, Tawbi HA, Sheshadri A, Lee JJ, Jaffray D, D Code Team, Wu CC, Chung C, Wu J. Habitat Imaging Biomarkers for Diagnosis and Prognosis in Cancer Patients Infected with COVID-19. Cancers (Basel) 15(1), 2022. e-Pub 2022. PMID: 36612278.
      12. Chen P, Saad MB, Rojas FR, Salehjahromi M, Aminu M, Bandyopadhyay R, et al LH. Cellular Architecture on Whole Slide Images Allows the Prediction of Survival in Lung Adenocarcinoma. International Workshop on Computational Mathematics Modeling in Cancer Analysis, 2022. e-Pub 2022.
      13. Chen P, El Hussein S, Xing F, Aminu M, Kannapiran A, Hazle JD, Medeiros LJ, Wistuba II, Jaffray D, Khoury JD, Wu J. Chronic Lymphocytic Leukemia Progression Diagnosis with Intrinsic Cellular Patterns via Unsupervised Clustering. Cancers (Basel) 14(10), 2022. e-Pub 2022. PMID: 35626003.
      14. Aminu, M, Ahmad, NA. Locality preserving partial least squares discriminant analysis for face recognition. Journal of King Saud University - Computer and Information Sciences 34(2):153-164, 2022. e-Pub 2022.
      15. Chen P, Aminu M, Hussein SE, Khoury JD, Wu J. CellSpatialGraph: Integrate hierarchical phenotyping and graph modeling to characterize spatial architecture in tumor microenvironment on digital pathology. Softw Impacts 10, 2021. e-Pub 2021. PMID: 36203948.
      16. Aminu M, Ahmad NA, Noor MHM. Covid-19 detection via deep neural network and occlusion sensitivity maps. Alexandria Engineering Journal Volume 60(Issue 5):4829-4855, 2021. e-Pub 2021.
      17. Chen P, Aminu M, Hussein SE, Khoury JD, Wu AJ. Hierarchical phenotyping and graph modeling of spatial architecture in lymphoid neoplasms. Medical Image Computing and Computer Assisted Intervention–MICCAI 2021: 24th International Conference, 2021. e-Pub 2021.
      18. Aminu M, Ahmad NA. Complex Chemical Data Classification and Discrimination Using Locality Preserving Partial Least Squares Discriminant Analysis. ACS Omega 5(41):26601-26610, 2020. e-Pub 2020. PMID: 33110988.
      19. Aminu M, Ahmad NA. New Variants of Global-Local Partial Least Squares Discriminant Analysis for Appearance-Based Face Recognition. IEEE Access Volume 8:166703 - 166720, 2020. e-Pub 2020.
      20. Aminu M, Ahmad NA. Uncorrelated Discriminant Projection Based on Maximum Margin Criterion and Its Kernelized Extension. The 2nd Joint International Conference on Emerging Computing Technology and Sports (JICETS) 2019 1529(1529(4):052070), 2020. e-Pub 2020.
      21. Aminu M, Ahmad NA, Awang N. Feature extraction and classification for spoken letter recognition using locality preserving partial least squares discriminant analysis. International Conference On Mathematical Sciences And Technology 2018 (Mathtech2018): Innovative Technologies for Mathematics & Mathematics for Technological Innovation Volume 2184(Issue 1), 2019. e-Pub 2019.
      22. Aminu M, Ahmad NA, Awang N. Feature Extraction Using Discriminant Graph Laplacian Principal Component Analysis with Application to Biomedical Datasets. International Conference on Biomedical Engineering Volume, 2019. e-Pub 2019.
      23. Aminu M, Ahmad NA, Awang N. A modified locality preserving partial least squares for classification problems. International Conference On Mathematics, Engineering And Industrial Applications 2018 (ICoMEIA 2018) Volume 2013(Issue 1), 2018. e-Pub 2018.
      24. Aminu A, Aminu M, Ringim MZ. Permanent of a rhotrix. Afrika Matematika Volume 28:481–491, 2016. e-Pub 2016.

      Abstracts

      1. Zhu, Li J, Chen H, Chen P, Fujimoto J, Tian Y, Aminu M, et al. Single Cell and Spatial Profiling Reveal Molecular and Immune Evolution from Precancers to Invasive Lung Adenocarcinomas in Genetic and Carcinogen-Induced Mouse Models. American Association for Cancer Research annual meeting Volume 83(Issue 7), 2023. e-Pub 2023.
      2. Aminu M, Vokes, Saad, Li, Hong, Mohamed, Boom. Tumor Volumetric Analysis to Correlate Disease Burden with Response to Dual Immune Checkpoint Blockade in Metastatic NSCLC. American Association for Cancer Research annual meeting 83(7):4393-93, 2023. e-Pub 2023.
      3. Chen,P, Rojas F, Hu X, Fujimoto J, Serrano A, Zhu B, Hong L, Bandyopadhyay R, Aminu M, et al.. Pathomics Reveals the Molecular and Immune Evolution from Lung Preneoplasia to Invasive Adenocarcinoma. American Association for Cancer Research annual meeting, 2023. e-Pub 2023.
      4. Hong, Aminu M, Lu X, Saad MB, Chen P, Rinsurongkawong W, Spelman A, et al. Genomic and Clinical Predictors of Early Disease Progression and Chemoimmunotherapy Benefit in Advanced NSCLC. American Association for Cancer Research annual meeting 83(7_Supplement):5443-43, 2023. e-Pub 2023.
      5. Hong, Rinsurongkawong W, Saad MB, Chen P, Aminu M, Spelman AR, Negrao MV, Cascone, Lin, Lee, Sepesi, Lewis, Gibbons, Vaporciyan, Lee, Le, Wu, Heymach, Zhang, Vokes. Real-World Effectiveness of Immune Checkpoint Inhibitors Alone or in Combination with Chemotherapy in Metastatic Non–Small Cell Lung Cancer. 2022 American Society of Clinical Oncology Annual Meeting I 40(16):9055-9055, 2022. e-Pub 2022.
      6. Saad, Hong L, Aminu M, Vokes NI, Chen P, Wu CC, Rinsurongkawong W, Spelman, Negrao, Cascone, Lin, Lee, Sepesi, Gibbons, Vaporciyan, Lee, Le, Zhang, Wu, Heymach. Deep Learning Signature from Chest Ct and Association with Immunotherapy Outcomes in EGFR/Alk-Negative NSCLC.". 2022 American Society of Clinical Oncology Annual Meeting I 40(16), 2022. e-Pub 2022.
      Read More
      Less

      Patient Reviews


      CV information above last modified July 22, 2026

      Request an Appointment

      Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
      Learn more

      Related Links

      • Care Centers and Clinics

      • Departments and Divisions

      • Labs

      Clinical Trials

      Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
      Learn more

      Help #EndCancer

      Give Now

      Your gift will help make a tremendous difference.
      Donate

      Donate Blood

      Our patients depend on blood and platelet donations.

      Make an appointment

      Shop UT MD Anderson

      Show your support for our mission through branded merchandise.

      View products
      Subscribe to our Cancerwise newsletter
      UT MD Anderson logoUT MD Anderson logo
      • Explore
      • Patients & Family
      • Prevention & Screening
      • Donors & Volunteers
      • For Physicians
      • Research
      • Education & Training
      • Clinical Trials
      • Languages
      • About
      • About UT MD Anderson
      • Careers
      • Blog
      • Newsroom
      • Editorial Standards
      • For Employees
      • Merchandise
      • Title IX Reporting (Sexual Misconduct)
      • Price Transparency
      • Finding Your Way
      • Our Doctors
      • Locations
      • Directions
      • Sitemap
      • DIGITAL ACCESSIBILITY
      • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
      • GET IN TOUCH
      • Call
        1-877-632-6789
      • Ask a question
      • Stay Connected
      • Cancerwise Podcast
      • More
      • Website Privacy Policy
      • Legal Statement & Policies
      • Reports to the State
      • Emergency Alert Information
      • State of Texas Links
      • Our Cancer Network
      • Vendors & Suppliers
      UT MD Anderson logo
      The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

      © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

      Top